Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway

References

• Cruz CSD, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32:605.
   PubMed Web of Science ®Google Scholar
• Ridge CA, Mcerlean AM, Ginsberg MS. Epidemiology of lung cancer. Chest. 2003;123:93–98.
   Google Scholar
• Cancer UK. Lung cancer survival statistics. 2015.
   Google Scholar
• Hann CL, Rudin CM. Management of small-cell lung cancer: incremental changes but hope for the future. Oncology (Williston Park, NY). 2008;22:1486–1492.
   PubMed Web of Science ®Google Scholar
• Group MAC. Chemotherapy in addition to supportive care improves survival in advanced non–small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol. 2008;26:4617.
   PubMed Web of Science ®Google Scholar
• Kelly GS. Rhodiola rosea: a possible plant adaptogen. Altern Med Rev. 2001;6:293.
   PubMedGoogle Scholar
• Perfumi M, Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res. 2007;21:37–43.
   PubMed Web of Science ®Google Scholar
• Xu MC, Shi HM, Wang H, et al. Salidroside protects against hydrogen peroxide-induced injury in HUVECs via the regulation of REDD1 and mTOR activation. Mol Med Rep. 2013;8:147–153.
   PubMed Web of Science ®Google Scholar
• Wang H, Ding Y, Zhou J, et al. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine. 2009;16:146–155.
   PubMed Web of Science ®Google Scholar
• Li D, Fu Y, Zhang W, et al. Salidroside attenuates inflammatory responses by suppressing nuclear factor-κB and mitogen-activated protein kinases activation in lipopolysaccharide-induced mastitis in mice. Inflamm Res. 2013;62:9–15.
   PubMed Web of Science ®Google Scholar
• Choe KI, Kwon JH, Park KH, et al. The antioxidant and anti-inflammatory effects of phenolic compounds isolated from the root of Rhodiola sachalinensis A. BOR. Molecules. 2012;17:11484–11494.
   PubMed Web of Science ®Google Scholar
• Qian EW, Ge DT, Kong SK. Salidroside promotes erythropoiesis and protects erythroblasts against oxidative stress by up-regulating glutathione peroxidase and thioredoxin. J Ethnopharmacol. 2011;133:308–314.
   PubMed Web of Science ®Google Scholar
• Hu X, Zhang X, Qiu S, et al. Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochem Biophys Res Commun. 2010;398:62–67.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li X, Simoneau AR, et al. Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy. Mol Carcinog. 2012;51:257–267.
   PubMed Web of Science ®Google Scholar
• Sun KX, Xia HW, Xia RL. Anticancer effect of salidroside on colon cancer through inhibiting JAK2/STAT3 signaling pathway. Int J Clin Exp Pathol. 2015;8:615.
   PubMed Web of Science ®Google Scholar
• Sun C, Wang Z, Zheng Q, et al. Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells. Phytomedicine. 2012;19:355–363.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu H, Sun Y, et al. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol. 2007;564:18–25.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yao Y, Wang H, et al. Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment. Chinese J Cancer Res. 2013;25:520.
   PubMed Web of Science ®Google Scholar
• Hu X, Lin S, Yu D, et al. A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines. Cell Biol Toxicol. 2010;26:499.
   PubMed Web of Science ®Google Scholar
• Wang J, Jian-Zhe LI, Ai-Xia LU, et al. Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression. Oncol Lett. 2014;7:1159–1164.
   PubMed Web of Science ®Google Scholar
• Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005;9:59–71.
   PubMed Web of Science ®Google Scholar
• Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 2003;22:395–403.
   PubMed Web of Science ®Google Scholar
• Guo H, Li W, Zheng T, et al. MiR-195 targets HDGF to inhibit proliferation and invasion of NSCLC cells. Tumor Biol. 2014;35:8861–8866.
   PubMedGoogle Scholar
• Liu B, Qu J, Xu F, et al. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1. Oncotarget. 2015;6:9445–9456.
   PubMedGoogle Scholar
• Butler MS. The role of natural product chemistry in drug discovery. J Nat Prod. 2004;67:2141–2153.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311–335.
   PubMed Web of Science ®Google Scholar
• Marchetti S, Mazzanti R, Beijnen JH, et al. Concise review: clinical relevance of drug–drug and herb–drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist. 2007;12:927–941.
   PubMed Web of Science ®Google Scholar
• Baldin V, Lukas J, Marcote MJ, et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Develop. 1993;7:812–821.
   PubMed Web of Science ®Google Scholar
• Wang C, Li Z, Fu M, et al. Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential. Cancer Treat Res. 2004;119:217–237.
   PubMedGoogle Scholar
• Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther. 2002;1:226–231.
   PubMed Web of Science ®Google Scholar
• Buckley MF, Sweeney KJ, Hamilton JA, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 1993;8:2127–2133.
   PubMed Web of Science ®Google Scholar
• Jiang W, Zhang Y-J, Kahn SM, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci. 1993;90:9026–9030.
   PubMed Web of Science ®Google Scholar
• Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005;65:3980–3985.
   PubMed Web of Science ®Google Scholar
• Mook OR, Frederiks WM, Van Noorden CJ. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta. 2004;1705:69–89.
   PubMed Web of Science ®Google Scholar
• Braicu EI, Gasimli K, Richter R, et al. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer – results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial. Anticancer Res. 2014;34:385–391.
   PubMed Web of Science ®Google Scholar
• Rath N, Olson MF. Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy. Embo Rep. 2012;13:900–908.
   PubMed Web of Science ®Google Scholar
• Leader M, Collins M, Patel J, et al. Vimentin: an evaluation of its role as a tumour marker. Histopathology. 1987;11:63
   PubMed Web of Science ®Google Scholar
• Qiao M, Chang X, Jing F, et al. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signall. 2006;18:2262–2271.
   PubMed Web of Science ®Google Scholar
• Derijard B, Raingeaud J, Barrett T, et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 1995;267:682–685.
   PubMed Web of Science ®Google Scholar
• Antón I, Molina E, Luis-Ravelo D, et al. Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med. 2012;186:96–105.
   PubMed Web of Science ®Google Scholar